Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Published:

STRIPE partners in precision medicine series: pharmacist perspective

The Pharmacogenomics Journal volume 24, Article number: 26 (2024) Cite this article

Subjects

Currently, various commercial and healthcare-system laboratories offer pharmacogenomic testing, and patients are referred by healthcare providers for testing to optimize drug therapy. Based on the profession’s expertise in pharmacology, pharmacokinetics, and drug interactions, a pharmacist is often consulted to review and summarize all the clinical and pharmacogenomics information to provide clinical recommendations. In this common workflow, each stakeholder is faced with unique issues and complexities that impact different facets of pharmacogenomics. The Partners in Precision Medicine series was held to bridge mutual understanding, align common goals to standardize key issues, and pave a way forward for clinical implementation of precision medicine.

During the “Pharmacist Perspective” session, Dr. Mark Dunnenberger, Dr. Amina Abubakar, and Dr. Roseann Gammal (now Donnelly) shared their insights during a discussion co-moderated by Dr. David Kisor and Dr. Ben Kong. Panelists were invited to describe some of the successes and challenges of incorporating pharmacogenomics into their daily practice, with perspectives ranging from a large healthcare institution to an independent community practice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

References

  1. Vo TT, Bell GC, Owusu Obeng A, Hicks JK, Dunnenberger HM. Pharmacogenomics implementation: considerations for selecting a reference laboratory. Pharmacotherapy. 2017;37:1014–22.

    Article  PubMed  Google Scholar 

  2. Relling MV, Klein TE, Gammal RS, Whirl-Carrillo M, Hoffman JM, Caudle KE. The clinical pharmacogenetics implementation consortium: 10 years later. Clin Pharmacol Ther. 2020;107:171–5.

    Article  PubMed  Google Scholar 

  3. Pratt VM, Cavallari LH, Del Tredici AL, Gaedigk A, Hachad H, Ji Y, et al. Recommendations for Clinical CYP2D6 genotyping allele selection: a joint consensus recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy. J Mol Diagn. 2021;23:1047–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Pratt VM, Del Tredici AL, Hachad H, Ji Y, Kalman LV, Scott SA, et al. Recommendations for Clinical CYP2C19 genotyping allele selection: a report of the association for molecular pathology. J Mol Diagn. 2018;20:269–76.

    Article  CAS  PubMed  Google Scholar 

  5. Pratt VM, Cavallari LH, Del Tredici AL, Hachad H, Ji Y, Moyer AM, et al. Recommendations for Clinical CYP2C9 genotyping allele selection: a joint recommendation of the Association for Molecular Pathology and College of American Pathologists. J Mol Diagn. 2019;21:746–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gammal RS, Mayes J, Caudle KE. Ready or not, here it comes: direct-to-consumer pharmacogenomic testing and its implications for community pharmacists. J Am Pharm Assoc. 2019;59:646–50.

    Article  Google Scholar 

Download references

Acknowledgements

The Partners in Precision Medicine series was developed by the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Initiative Education Team. STRIPE is a Collaborative Community, serving as a continuing forum in which private- and public-sector members, including the FDA, work together on medical device challenges to achieve common objectives and outcomes. More information about the STRIPE Initiative can be found by visiting https://www.stopadr.org/stripe. To view the complete “Partners in Precision Medicine” webinar series, visit https://tvworldwide.com/events/pipm/210929/default.cfm.

Author information

Authors and Affiliations

  1. Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA

    Ben L. Kong

  2. Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA

    Roseann S. Donnelly

  3. Avant Pharmacy and Wellness, Charlotte, NC, USA

    Amina Abubakar

  4. Pharmacogenomics, Mark R. Neaman Center for Personalized Medicine, NorthShore University Health System, 2650 Ridge Avenue, Evanston, IL, 60201, USA

    Henry M. Dunnenberger

  5. Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy, Dallas, TX, USA

    J. Shawn Jones

  6. Department of Pharmacy Practice, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, TX, USA

    Sara L. Rogers

  7. Department of Translational Medical Sciences, School of Medicine, Texas A&M University, Bryan, TX, USA

    Sara L. Rogers

  8. Center for Genomic and Precision Medicine, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA

    Sara L. Rogers

  9. American Society of Pharmacovigilance, Houston, TX, USA

    Sara L. Rogers

  10. Department of Pharmaceutical Sciences, Manchester University, Fort Wayne, IN, USA

    David Kisor

Authors
  1. Ben L. Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roseann S. Donnelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amina Abubakar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Henry M. Dunnenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Shawn Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sara L. Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. David Kisor
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SLR, JSJ, BLK, DK was responsible for designing the webinar series concept. BLK, RSD, AA, HMD contributed to writing the report.

Corresponding author

Correspondence to Ben L. Kong.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kong, B.L., Donnelly, R.S., Abubakar, A. et al. STRIPE partners in precision medicine series: pharmacist perspective. Pharmacogenomics J 24, 26 (2024). https://doi.org/10.1038/s41397-024-00347-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41397-024-00347-w

Search

Advanced search

Quick links